Drugmakers Launch Generic Imitrex

The FDA has approved nine drugmakers’ ANDAs for generic versions of GlaxoSmith-Kline’s (GSK) migraine treatment Imitrex. Mylan, Sandoz, Dr. Reddy’s Laboratories, Roxane Laboratories, Cobalt Laboratories, Orchid Healthcare, Aurobindo Pharma and Sun Pharmaceutical Industries all received approval for 25-, 50- and 100-mg sumatriptan succinate tablets. Ranbaxy Laboratories won approval for its 25- and 50-mg strengths the same day and will launch the product immediately, according to a recent statement.
Generic Line